Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Shares Outstanding (Diluted Average) (2021 - 2023)

Historic Shares Outstanding (Diluted Average) for Cullinan Therapeutics (CGEM) over the last 3 years, with Q3 2023 value amounting to $42.7 million.

  • Cullinan Therapeutics' Shares Outstanding (Diluted Average) fell 825.68% to $42.7 million in Q3 2023 from the same period last year, while for Sep 2023 it was $42.7 million, marking a year-over-year decrease of 825.68%. This contributed to the annual value of $46.6 million for FY2022, which is 827.12% up from last year.
  • Per Cullinan Therapeutics' latest filing, its Shares Outstanding (Diluted Average) stood at $42.7 million for Q3 2023, which was down 825.68% from $40.3 million recorded in Q2 2023.
  • In the past 5 years, Cullinan Therapeutics' Shares Outstanding (Diluted Average) ranged from a high of $46.6 million in Q4 2022 and a low of $40.3 million during Q2 2023
  • Its 3-year average for Shares Outstanding (Diluted Average) is $43.8 million, with a median of $43.4 million in 2021.
  • In the last 5 years, Cullinan Therapeutics' Shares Outstanding (Diluted Average) surged by 827.12% in 2022 and then tumbled by 1309.36% in 2023.
  • Over the past 3 years, Cullinan Therapeutics' Shares Outstanding (Diluted Average) (Quarter) stood at $43.1 million in 2021, then increased by 8.27% to $46.6 million in 2022, then fell by 8.37% to $42.7 million in 2023.
  • Its Shares Outstanding (Diluted Average) was $42.7 million in Q3 2023, compared to $40.3 million in Q2 2023 and $40.7 million in Q1 2023.